These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 494895)

  • 1. [Use of anaplyxasis for evaluating the reactogenicity of commercial strains and series of a vaccine virus].
    Vorob'ev AA; Afanas'ev SS; Patrikeev GT; Podkuĭko VN; Pashanina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Aug; (8):14-7. PubMed ID: 494895
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein.
    Ohishi K; Inui K; Barrett T; Yamanouchi K
    J Gen Virol; 2000 Jun; 81(Pt 6):1439-46. PubMed ID: 10811927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus strain differences. II. Altered dermal reactivity of vaccinia virus by single passage in a new host system.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):117-24. PubMed ID: 4747046
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of smallpox vaccines prepared from strains of different reactogenicity.
    Nyerges G; Csukás M
    Acta Microbiol Acad Sci Hung; 1972; 19(2):103-9. PubMed ID: 4670218
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):107-16. PubMed ID: 4126981
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins.
    Verardi PH; Aziz FH; Ahmad S; Jones LA; Beyene B; Ngotho RN; Wamwayi HM; Yesus MG; Egziabher BG; Yilma TD
    J Virol; 2002 Jan; 76(2):484-91. PubMed ID: 11752138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus.
    De BK; Shaw MW; Rota PA; Harmon MW; Esposito JJ; Rott R; Cox NJ; Kendal AP
    Vaccine; 1988 Jun; 6(3):257-61. PubMed ID: 3048009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses of guinea-pigs, rabbits and pigs to inactivated porcine parvovirus vaccines.
    Joo HS; Molitor TW; Leman AD
    Vet Microbiol; 1984 Feb; 9(1):27-33. PubMed ID: 6719818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV).
    Jordão RS; Ribeiro CP; Pituco EM; Okuda LH; Del Fava C; Stefano Ed; Filho MM; Mehnert DU
    Res Vet Sci; 2011 Oct; 91(2):311-5. PubMed ID: 21316721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of hemagglutinin in the vaccinia virion.
    Marquardt J
    Arch Gesamte Virusforsch; 1971; 35(2):133-42. PubMed ID: 5002905
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunisation of cattle with a recombinant vaccinia vector expressing the haemagglutinin gene of rinderpest virus.
    Yamanouchi K; Inui K; Sugimoto M; Asano K; Nishimaki F; Kitching RP; Takamatsu H; Barrett T
    Vet Rec; 1993 Feb; 132(7):152-6. PubMed ID: 8456545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.
    Andrew ME
    Immunol Cell Biol; 1989 Oct; 67 ( Pt 5)():339-41. PubMed ID: 2613281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
    Julander JG; Testori M; Cheminay C; Volkmann A
    Front Immunol; 2018; 9():1756. PubMed ID: 30116244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heat-labile factors on the neutralization of vaccinia virus by human.
    Takabayashi K; McIntosh K
    Infect Immun; 1973 Oct; 8(4):582-9. PubMed ID: 4200542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and virological characterization of improved construction of recombinant vaccinia virus expressing rinderpest virus hemagglutinin.
    Asano K; Tsukiyama K; Shibata S; Yamaguchi K; Momoki T; Maruyama T; Kohara M; Miki K; Sugimoto M; Yoshikawa Y
    Arch Virol; 1991; 116(1-4):81-90. PubMed ID: 2001178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenic properties of foot-and-mouth vaccines].
    Tekerlekov P; Nikolova E; Dilovski M
    Vet Med Nauki; 1983; 20(5-6):46-51. PubMed ID: 6318424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus.
    Jones L; Giavedoni L; Saliki JT; Brown C; Mebus C; Yilma T
    Vaccine; 1993; 11(9):961-4. PubMed ID: 8212844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reexamination of the efficacy of vaccination against mousepox.
    Buller RM; Wallace GD
    Lab Anim Sci; 1985 Oct; 35(5):473-6. PubMed ID: 2997541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of the in vitro trimming of haemagglutinins from the particles of vaccinia and Ranikhet disease viruses by the lysates of the cells of virus infected CAM cultures.
    Babbar OP; Chowdhury BL
    Indian J Med Res; 1974 Nov; 62(11):1612-8. PubMed ID: 4475663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.